Brain lipopigment accumulation in normal and pathological aging

Annals of the New York Academy of Sciences

Volumn 1067, Issue 1, 2006, Pages 158-163

  Riga, Dan ^a   Riga, Sorin ^a   Halalau, Florin ^b   Schneider, Francisc ^c  

^a Alexandru Obregia Psychiatric Hospital Bucharest   (Romania)

^b VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^c Center for Applied Physiology and Molecular Biology   (Romania)

Author keywords

Glial cells; Lipopigments; Neurons; Neuropathology

Indexed keywords

CEROID; LIPOFUSCIN; LIPOPROTEIN;

AGING; BRAIN CELL; CELL COMPARTMENTALIZATION; CENTRAL NERVOUS SYSTEM; CLUSTER ANALYSIS; CONFERENCE PAPER; CYTOARCHITECTURE; GLIA CELL; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; NERVE CELL; NERVE FUNCTION; NEUROPATHOLOGY; ONTOGENY; PATHOLOGY; TISSUE SPECIFICITY;

EID: 33744468524     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1354.019     Document Type: Conference Paper

References (18)

1. Landfield, P.W., R.K. Baskin & T.A. Pitler. 1981. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science 214: 581 584.
2. Riga, D. & S. Riga. 1998. Correlations between lipofuscin accumulation and aging neuropathology. Ann. N.Y. Acad. Sci. 854: 495.
3. Lynch, G. & X. Bi. 2003. Lysosomes and brain aging in mammals. Neurochem. Res. 28: 1725 1734.
4. Brunk, U.T. & A. Terman. 2002. The mitochondrial-lysosomal axis theory of aging: accumulation of damage as a result of imperfect autophagocytosis. Eur. J. Biochem. 269: 1996 2002.
5. Riga, S. & D. Riga. 1995. An antistress and antiaging neurometabolic therapy: accelerated lipo-fuscinolysis and stimulated anabolic regeneration by the Antagonic-Stress synergistic formula. Ann. N.Y. Acad. Sci. 771: 535 550.
6. Braak, H. & E. Braak. 1988. Morphology of the human isocortex in young and aged individuals: qualitative and quantitative findings. In Histology and Histopathology of the Aging Brain. J. Ulrich, Ed 1 15. Karger. Basel.
7. Porta, E.A. 1991. Advances in age pigment research. Arch. Gerontol. Geriatr. 12: 303 320.
8. Cervós-Navarro, J. & H.-I. Sarkander, Eds. 1983. Brain Aging: Neuropathology and Neuropharmacology. Raven Press. New York, NY.
9. Finch, C.E., I. Rozovsky, D. Stone, et al. 1999. Glial activation during aging in the rat brain: gene expression and proliferative potential. In Molecular Biology of Aging. V. A. Bohr, B. F. C. Clark & T. Stevnsner, Eds 304 315. Alfred Benzon Symposium 44. Munksgaard, Copenhagen, DK.
10. Gonzáles-Scarano, F. & G. Baltuch. 1999. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22: 219 240.
11. Beckman, K.B. & B.N. Ames. 1998. The free radical theory of aging matures. Physiol. Rev. 78: 547 581.
12. Fosslien, E. 2001. Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann. Clin. Lab. Sci. 31: 25 67.
13. Terman, A. & U.T. Brunk. 2004. Aging as a catabolic malfunction. Int. J. Biochem. Cell Biol. 36: 2365 2375.
14. Riga, D., S. Riga & F. Schneider. 2004. Regenerative medicine: Antagonic-Stress® therapy in distress and aging. I. Preclinical synthesis - 2003. Ann. N.Y. Acad. Sci. 1019: 396 400.
15. Grune, T., T. Jung, K. Merker, et al. 2004. Decreased proteolysis caused by protein aggregates inclusion bodies, plaques, lipofuscin, ceroid, and "aggresomes" during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36: 2519 2530.
16. Keck, S., R. Nitsch, T. Grune, et al. 2003. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85: 115 122.
17. Stolzing, A. & T. Grune. 2004. Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells. FASEB J. 18: 743 765.
18. Rattan, S.I.S. 2005. Principles and practice of hormesis as an aging intervention. In Aging Interventions and Therapies. S.I.S. Rattan, Ed 365 377. World Scientific. Singapore.